UK MHRA · April 01, 2026

Guidance: Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway

MHRA-NICE aligned pathway streamlines decision-making to accelerate patient access to new medicines by 3–6 months.

High obligation Sector Pharmaceuticals Market Access & Reimbursement UK PharmaceuticalsReimbursement

By streamlining decision-making, the MHRA–NICE aligned pathway will help patients access new medicines 3–6 months sooner.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.